Pharmaniaga has signed an MOU with JDMAS Commerce Sdn Bhd which manages distrubution of Malaysian products into China, to penetrate the mainland market for its over the counter and generic pharmaceutical products.
Under the agreement, both parties will collaborate in registering, importing, distributing, and marketing PHARMANIAGA’s over the counter products (OTC) and generic pharmaceutical products into China market through the digital e-commerce platform, JD.com.
JDMAS was established as a launchpad for Malaysian companies to penetrate and grow their brands globally, focusing mainly in China. It provides a platform for the client merchants to leverage the extensive technology-driven platforms provided by JD.com and its affiliates such as Douyin, Kwaishou, and WeChat. The platforms are supported by a comprehensive ecosystem of digital tools, data, warehouse, cross-border freight and last mile freight, payment systems, and offline channels situated across the market we operate in.
JDMAS will also support Pharmaniaga for the regulation, commercial trade, and supply chain operations for China’s consumer healthcare, nutraceuticals, generic drugs, and medical devices market which includes facilitation and support in the application as necessary. It will also help identify Pharmaniaga’s niche products with the least competition from its competitor within the China market.
